Evaluating the Cardiovascular Event Profile After Administration of Tixagevimab and Cilgavimab (Evusheld) in Lung Transplant Recipients

被引：0
|
作者：
Bulger, J. L. [1 ]
Ching, K. [2 ]
Joyce, C. [3 ]
Warrior, K. [1 ]
机构：
[1] Loyola Univ Med Ctr, Pulm Crit Care, Maywood, IL USA
[2] Loyola Univ Med Ctr, Internal Med, Maywood, IL USA
[3] Loyola Univ Med Ctr, Ctr Translat Res & Educ, Maywood, IL USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6578
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Use of Tixagevimab and Cilgavimab (Evusheld) and Subsequent Outcomes of SARS-CoV-2 Infections in Lung Transplant Recipients
    Grillini, A.
    Stracener, P.
    Scarola, D.
    Lyons, J.
    Dilling, D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S311 - S311
  • [2] Protective measures against Omicron could be more effective than cilgavimab/tixagevimab (Evusheld®) in liver transplant recipients
    Odriozola Herran, Aitor
    Fortea Ormaechea, Jose Ignacio
    Cuadrado Lavin, Antonio
    Puente Sanchez, Angela
    Lazarus, Jeffrey
    Crespo, Javier
    Fabrega, Emilio
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (12) : 769 - +
  • [3] TIXAGEVIMAB AND CILGAVIMAB (EVUSHELD) FOR PRE-EXPOSURE PROPHYLAXIS OF COVID-19: AMONOCENTRIC STUDY IN KIDNEY TRANSPLANT RECIPIENTS
    Stefanelli, Lucia Federica
    Alessi, Marianna
    Ungaro, Claudia
    Ciotti, Chiara
    Calo, Lorenzo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I942 - I942
  • [4] Experience with Pre- and Post-Exposure Prophylaxis with Tixagevimab and Cilgavimab in Lung Transplant Recipients
    Kinnunen, P.
    Lemstrom, K.
    Nykanen, A.
    Tikkanen, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S459 - S459
  • [5] Safety of intramuscular tixagevimab-cilgavimab (Evusheld®) administration in patients at risk of iatrogenic haematoma due to haematological disorders
    Malherbe, Jacques A. J.
    Misko, Jeanie
    Jayawardena, Nishani K.
    Rawlins, Matthew D. M.
    Manning, Laurens
    Purtill, Duncan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [6] Tixagevimab/cilgavimab for the prevention of COVID-19 in solid organ transplant recipients
    Eribes, Emily
    Votruba, Cassandra
    Tinkham, Tyler
    Huang, Angela
    Ilges, Dan
    Kunze, Katie
    Hudson, Madeline
    CLINICAL TRANSPLANTATION, 2024, 38 (02)
  • [7] Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients
    Benotmane, Ilies
    Olagne, Jerome
    Gautier-Vargas, Gabriela
    Cognard, Noelle
    Heibel, Francoise
    Braun-Parvez, Laura
    Keller, Nicolas
    Martzloff, Jonas
    Perrin, Peggy
    Pszczolinski, Romain
    Moulin, Bruno
    Fafi-Kremer, Samira
    Caillard, Sophie
    TRANSPLANTATION, 2023, 107 (08) : E215 - E218
  • [8] Single-Center Review of Tixagevimab-Cilgavimab Use in Solid Organ Transplant Recipients
    Shaikh, S.
    Davoudi, R.
    Kawewat-Ho, P.
    Cartus, R.
    Morado, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S660 - S661
  • [9] The Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in Preventing Severe Sars-Cov-2 (covid) Infection After Kidney Transplantation
    Splinter, J.
    Froehlich, M.
    Kaur, P.
    Delgado-Saldana, J.
    Jaleco, M.
    Asad, S.
    Patel, S. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S946 - S947
  • [10] Pre- Exposure Tixagevimab/Cilgavimab Monoclonal Antibodies Reduces Severe Covid-19 Infection in Lung Transplant Recipients
    Rao, S.
    Floyd, S.
    Mannem, H.
    Maddox, M.
    Kamal, J.
    Nishio-Lucar, A.
    Doyle, A.
    Sharma, B.
    Weder, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S467 - S467
12345